Global private equity and venture capital news and research

Posts Tagged ‘Devon Park Bioventures’

19 May 2014

US biopharma Proteon Therapeutics raises $45m Series D

US biopharmaceutical company Proteon Therapeutics has closed a $45m of Series D equity financing, including a $25m tranche to fully fund the first Phase 3 clinical study of its lead product.

27 September 2013

Inotek venture backers look to advance lead glaucoma product with $19m financing

The venture backers of glaucoma treatment business Inotek Pharmaceuticals have spent another $21m financing the business to help it advance its lead product.

29 October 2012

Texas pharmaceutical company ZS Pharma closes $46m venture round

blood_vein_170sq Texas-based pharmaceutical company ZS Pharma has raised $46m to advance the development of ZS-9, a crystal form of zirconium silicate designed to treat patients with kidney and liver disease.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016